DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 19:03:39 31/05/2024 BST | ||
| 199.6 EUR | +1.83% |
|
| Current month | +1.38% | ||
| 1 month | +1.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 199.6 | +1.83% |
| 30/05/24 | 196 | +0.92% |
| 29/05/24 | 194.2 | -0.14% |
| 28/05/24 | 194.5 | -0.33% |
| 27/05/24 | 195.1 | -0.03% |
Delayed Quote Deutsche Boerse AG
Last update May 31, 2024 at 07:03 pm
More quotesStatic data
| Product type | Discount-Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM5USQ |
| ISIN | DE000VM5USQ3 |
| Date issued | 22/11/2023 |
| Maturity | 20/09/2024 (111 Days) |
| Parity | 1 : 1 |
| Emission price | 192.9 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 203.9 € |
|---|---|
| Lowest since issue | 176.7 € |
| Spread | 0.21 € |
| Spread % | 0.11% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
